Skip to main content

E-Learning Course - cGMP

|   Announcement

As a result of the Covid-19 pandemic, many manufacturing sites on the African continent had to scale down their pharmaceutical production due to lockdowns, supply shortages and stock-outs of imported active ingredients and other excipients. These supply shortages show once again the importance of local production of medicines and medical devices in accordance with international standards for the independence and sustainable development of African countries.

In order to resume and continue production - even in times of a pandemic - it is essential that manufacturers are able to comply with local hygiene regulations and provide adequate protection for their workers from the infection with the virus.

Back